Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. [electronic resource]
Producer: 20150716Description: 631-638.e7 p. digitalISSN:- 1097-6744
- Acute Coronary Syndrome -- drug therapy
- Aged
- Cardiovascular Diseases
- Double-Blind Method
- Female
- Glucagon-Like Peptide 1 -- agonists
- Humans
- Male
- Middle Aged
- Peptides -- pharmacology
- Placebos
- Protein Kinase Inhibitors -- therapeutic use
- Research Design
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.